Investigation of sinus vein thrombosis cases detected in the emergency department

Yıl 2021, Cilt: 4 Sayı: 4, 428 - 433, 15.07.2021

Ahmet Burak Erdem , Elif Çelikel , Muhittin Yılmaz , Berkin Karapınarlı , Uğur Bilgay Kaya

https://doi.org/10.32322/jhsm.911964

Cited By: 1

Öz

Objective: Sinus vein thrombosis often presents to the emergency department with headache and is a rare disease among all strokes. Epidemiological data on sinus vein thrombosis are insufficient. Our aim in this study is to examine the findings of patients with sinus vein thrombosis who applied to our emergency department.
Material and Method: 267 patients with suspected sinus vein thrombosis in patients who came to our emergency department between 2013-2018 were included in the study. Patients were divided into 2 groups as present and without sinus vein thrombosis. Women were divided into 3 subgroups as not pregnant, pregnant and postpartum period. Demographic data, comorbid diseases, hemogram parameters and radiological data of the patients were recorded in a form. The relationship of the data with sinus vein thrombosis was examined.
Results: Sinus vein thrombosis was detected in 19.48% of the patients. 76.3% of the patients were women. 65.4% of them were between the ages of 18-40. The most common complaint was headache with 51.9%. And most of the patients’ neurological examinations were normal. We found that hemoglobin <8.75 g/dL increased mortality and mean platelet volume was more effective in predicting mortality (AUC=0.846).
Conclusion: Sinus vein thrombosis is more common in women under 40 years of age. While headache is the most common reason for presentation, neurological examination is mostly normal. For this, magnetic resonance imaging and venography should be taken when the disease is suspected. Anemia and mean platelet volume may indicate poor prognosis.

Anahtar Kelimeler

Anemia, female, headache, mean platelet volume (MPV), sinus vein thrombosis

Proje Numarası

Yok

Kaynakça

• Kaya D. The diagnosis and treatment of cerebral venous thrombosis. Turk J Neurol 2017; 23: 94-104.
• Duman T, Uluduz D, Midi İ, et al. A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST Study. J Stroke Cerebrovasc Dis 2017; 26: 1848–57.
• Ferro JM, de Sousa DA. Cerebral venous thrombosis: an update. Curr Neurol Neurosci Rep 2019; 19: 1-9.
• Ruiz-Sandoval JL, Chiquete E, Bañuelos-Becerra LJ, et al. Cerebral venous thrombosis in a Mexican multicenter registry of acute cerebrovascular disease: the RENAMEVASC study. J Stroke Cerebrovasc Dis 2012; 21: 395-400.
• Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke 2012; 43: 3375–7.
• Pate SI, Obeid H, Matti L, Ramakrishna H, Shamoun FE. Cerebral venous thrombosis current and newer anticoagulant treatment options. Neurologist 2015; 20: 80-8.
• Kısabay A, Eda Cakıroğlu, Deniz Selcuki. Cerebral venous thrombosis: a case series and literature review. Yoğun Bakım Derg 2015; 6: 48-56.
• Masuhr F, Mehraein S, Einhaupl K. Cerebral venous and sinus thrombosis. J Neurol 2004; 251: 11-23.
• Erçel Ö, Süt HK. Sleep quality and quality of life in postpartum woman. J Turk Sleep Med 2020; 1: 23-30.
• Maali L, Sheema Khan S, Qeadan F, Ismail M, Ramaswamy D, Hedna VS. Cerebral venous thrombosis: continental disparities. Neurol Sci 2017; 38: 1963-8.
• Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis. Stroke 2004; 35: 664–70.
• Martinelli I, Passamonti SM, Maino A, et al. Pregnancy outcome after a first episode of cerebral vein thrombosis. J Thromb Haemost 2016; 14: 2386–93.
• Sidhom Y, Mansour M, Messelmani M, et al. cerebral venous thrombosis: clinical features, risk factors, and long-term outcome in a Tunisian Cohort. J Stroke Cerebrovasc Dis 2014; 23: 1291-5.
• Sassi SB, Touati N, Baccouche H, Drissi C, Romdhane NB, Hentati F. Cerebral venous thrombosis: a tunisian monocenter study on 160 patients. Clin Appl Thromb Hemost 2017; 2: 1005-9.
• English JD, Fields JD, Le S, Singh V. Clinical Presentation and long-term outcome of cerebral venous thrombosis. Neurocrit Care 2009; 11: 330–7.
• Lee DJ, Ahmadpour A, Binyamin T, Dahlin BC, Shahlaie K, Waldau B. Management and outcome of spontaneous cerebral venous sinus thrombosis in a 5-year consecutive single-institution cohort. J NeuroIntervent Surg 2017; 9: 34–8.
• Duran S, Özyurtlu D, Taşkapılıoğlu Ö, Hakyemez B, Bakar M. Cerebral venous sinus thrombosis: analysis of 27 cases. Turk J Cerebrovasc Dis 2014; 20: 87-93.
• Kamışlı Ö, Arslan D, Altınayar S, Kamışlı S, Kablan Y, Özcan C. Sinus thrombosis: clinical assessment. J Turk Cerebrovasc Dis 2009; 15; 39-42.
• Akgün H, Öz O, Taşdemir S, Alay S, Yücel M, Akgün V, et al. Cerebral Venous Sinus Thrombosis; Analysis Of 17 Cases. Gülhane Tıp Derg 2014; 56: 102-6.
• Ferro JM, Bousser MG, Canhao P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology. Eur J Neurol 2017; 24: 1203–13.
• Freeman CW, Lazor JW, Loevner LA, Nabavizadeh SA. Variations of the CNS venous system mimicking pathology: spectrum of ımaging findings. J Neuroimaging 2019; 29: 673-88.
• Coutinho JM, Zuurbier SM, Gaartman AE, et al. Association between anemia and cerebral venous thrombosis: case-control study. Stroke 2015; 46: 2735–40.
• Liu K, Song B, Gao Y, et al. Long‑term outcomes in patients with anemia and cerebral venous thrombosis. Neurocrit Care 2018; 29: 463-8.
• Kamışlı Ö, Kamışlı S, Kablan Y,Gönüllü S, Özcan C. The prognostic value of an ıncreased mean platelet volume and platelet distribution width in the early phase of cerebral venous sinus thrombosis. Clin Applied Thrombosis/Hemostasis 2013; 19: 29-32.
• Noris P, Melazzini F, Balduini CL. New roles for mean platelet volume measurement in the clinical practice? Platelets 2016; 27: 607-12.